Concepedia

A.M.L. van Delft

AV

32

Publications

1.4K

Citations

20

H-Index

1970

Active since

Affiliations

CNS Research (United States)(Current)

SNV Netherlands Development Organisation

Roche (Switzerland)

ET International (United States)

A.M.L. van Delft is an author at CNS Research (United States) specializing in medicine, neuropharmacology, and pharmacology.

Top concepts

Publications per year

1970–1998

32

Publications

32

5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutic Potential

Joel R. Martin, Michael Bös, F. Jenck et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 334 citations

Effects of serotonin receptor antagonists on PAG stimulation induced aversion: different contributions of 5HT1, 5HT2 and 5HT3 receptors

François Jenck, C.L.E. Broekkamp, A.M.L. van Delft · Psychopharmacology · 1989 · 74 citations

, , +12

Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats

François Jenck, Jean‐Luc Moreau, Hemmie H.G. Berendsen et al. · European Neuropsychopharmacology · 1998 · 69 citations

, , +11

Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro

Pierre N.M. Konings, W. Karolien Makkink, A.M.L. van Delft et al. · Brain Research · 1994 · 69 citations

, , +8

Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine

C.L.E. Broekkamp, S. K. Oosterloo, Hemmie H.G. Berendsen et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1988 · 63 citations

, , +8

Rows per page

1–5 of 32